Literature DB >> 26927474

The screening and evaluation of herbs and identification of herbal combinations with anti-viral effects on Newcastle disease virus.

M Wang1, Y Yu2, K Brad3, W Xie1, X-Y Zhang1.   

Abstract

A total of 25 "heat-clearing and detoxifying" herbs used in Chinese medicine were investigated for their cytopathic effects on the growth of Newcastle Disease virus (NDV) in a chicken fibroblast cell line. The 5 herbs with the highest virus inhibitory effects were Herba agastaches, Flos chrysanthemi indici, Rhizoma anemarrhenae, Astragalus root and Baikal skullcap root and these were used in herbal formulations. Anti-NDV activities of 4 formulations were tested on the growth of NDV in the DF-1 fibroblast cell line. Formulation II, containing Baikal skullcap root, Astragalus root, Anemarrhena rhizome (1:1:2) and formulation IV containing Anemarrhena rhizome, Astragalus root and Flos chrysanthemi indici (1:1:1), which had strong anti-NDV activity in vitro, were used to determine the in vivo inhibitory effects of NDV-infection in chickens. After treatment with the two formulations serum IgY titres against NDV were improved, and morbidity was reduced in the NDV-infected chickens. The results suggest that the components in formulations II and IV acted synergistically to improve resistance to Newcastle disease and provide a basis for the developing an anti-NDV herbal medicine.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26927474     DOI: 10.1080/00071668.2015.1119245

Source DB:  PubMed          Journal:  Br Poult Sci        ISSN: 0007-1668            Impact factor:   2.095


  2 in total

1.  Screening for antibacterial and antibiofilm activities in Astragalus angulosus.

Authors:  Hussein Kanaan; Majid El-Mestrah; Alaa Sweidan; Falah As-Sadi; Ali Al Bazzal; Ali Chokr
Journal:  J Intercult Ethnopharmacol       Date:  2016-10-27

2.  Honeysuckle (Lonicera japonica) and Huangqi (Astragalus membranaceus) Suppress SARS-CoV-2 Entry and COVID-19 Related Cytokine Storm in Vitro.

Authors:  Yuan-Chieh Yeh; Ly Hien Doan; Zi-Yi Huang; Li-Wei Chu; Tzu-Hau Shi; Ying-Ray Lee; Cheng-Tao Wu; Chao-Hsiung Lin; Shu-Tuan Chiang; Hui-Kang Liu; Tsung-Hsien Chuang; Yueh-Hsin Ping; Hsiao-Sheng Liu; Chi-Ying F Huang
Journal:  Front Pharmacol       Date:  2022-03-25       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.